HIT Consultant October 9, 2024
Sam Anwar, Chief Technology Officer, eClinical Solutions

McKinsey & Company estimates it takes up to 12 years to introduce a new drug to the market – a lengthy timeline comprised of many factors including technology limitations, regulatory requirements, and patient recruitment and retention. Scientific innovation and clinical trials are increasingly complex, generating more data than ever. Researchers are facing difficulties managing the volume and variety of data, turning to artificial intelligence, machine learning and advanced data architecture to improve data processing, user experiences, and outcomes.

However, one less discussed challenge within the drug discovery and development lifecycle is the ability of compute power to not only advance the data infrastructure needed but to also meet the increasing data demands of new and complex clinical trials. Building on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Technology
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article